Pfizer, Inc. (PFE) Q2 2026 Earnings Call

Investor webinar replay

Watch the replay and follow the connected company analysis, news, and investor updates for Pfizer, Inc..

Watch the replay

Replay transcript excerpt

WEBVTT 00:00:00.158 -- 00:00:05.161 Good day, everyone, and welcome to Pfizer's second quarter 2026 earnings conference 00:00:05.161 -- 00:00:08.723 call. Today's call is being recorded. 00:00:08.723 -- 00:00:13.105 At this time, I would like to turn the call over to Francesca DeMartino, chief investor 00:00:13.105 -- 00:00:16.087 relations officer and senior vice president. 00:00:16.087 -- 00:00:18.727 Please go ahead, ma'am. 00:00:19.149 -- 00:00:22.370 Good morning, and welcome to Pfizer's earnings call. 00:00:22.370 -- 00:00:26.193 I'm Francesca DeMartino, chief investor relations officer. 00:00:26.193 -- 00:00:29.349 On behalf of the Pfizer team, thank you for joining us. 00:00:29.349 -- 00:00:34.093 This call is being made available via audio webcast at Pfizer.com. 00:00:34.093 -- 00:00:38.977 Earlier this morning, we released our results for the second quarter of 2026 via a press 00:00:38.977 -- 00:00:43.181 release that is available on our website at Pfizer.com. 00:00:43.181 -- 00:00:48.225 I'm joined today by Dr. Albert Bourla, our chairman and CEO, Dave Denton, 00:00:48.225 -- 00:00:53.230 our CFO, Cécile Guégan, our incoming interim CFO, and 00:00:53.230 -- 00:00:56.615 Chris Boshoff, our chief scientific officer. 00:00:56.615 -- 00:01:00.378 After their prepared remarks, we will open the call for questions. 00:01:00.378 -- 00:01:04.261 Members of our leadership team will be available for the Q&A session. 00:01:04.261 -- 00:01:08.285 Before we get started, I want to remind you that we will be making forward-looking statements 00:01:08.285 -- 00:01:11.888 and discussing certain non-GAAP financial measures. 00:01:11.888 -- 00:01:16.131 I encourage you to read the disclaimers in our slide presentation, the press release 00:01:16.131 -- 00:01:20.815 we issued ...